In sepsis, continuous and intermittent infusion of β-lactam antibiotics did not differ for mortality at 90 d

Source CitationDulhunty JM, Brett SJ, De Waele JJ, et al; BLING III Study Investigators. Continuous vs intermittent β-lactam antibiotic infusions in critically ill patients with sepsis: the BLING III randomized clinical trial. JAMA. 12 June 2024. [Epub ahead of print.] https://pubmed.ncbi.nlm.nih.gov/38864155/AbstractClinical Impact RatingsGIM/FP/GP: Infectious Disease: Critical Care: